HLA Class I-T Cell Epitopes from trans-Sialidase Proteins Reveal Functionally Distinct Subsets of CD8+ T Cells in Chronic Chagas Disease

被引:58
作者
Alvarez, Marira G. [1 ]
Postan, Miriam [2 ]
Weatherly, D. Brent [3 ]
Albareda, Maria C. [2 ]
Sidney, John [4 ]
Sette, Alessandro [4 ]
Olivera, Carina [2 ]
Armenti, Alejandro H. [1 ]
Tarleton, Rick L. [3 ]
Laucella, Susana A. [2 ]
机构
[1] Hosp Interzonal Gen Agudos Eva Peron, San Martin, Buenos Aires, Argentina
[2] Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina
[3] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA
[4] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2008年 / 2卷 / 09期
基金
美国国家卫生研究院;
关键词
D O I
10.1371/journal.pntd.0000288
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Previously, we identified a set of HLA-A020.1-restricted trans-sialidase peptides as targets of CD8(+) T cell responses in HLA-A0201(+) individuals chronically infected by T. cruzi. Methods and Findings: Herein, we report the identification of peptides encoded by the same trans-sialidase gene family that bind alleles representative of the 6 most common class I HLA-supertypes. Based on a combination of bioinformatic predictions and HLA-supertype considerations, a total of 1001 epitopes predicted to bind to HLA A01, A02, A03, A24, B7 and B44 supertypes was selected. Ninety-six supertype-binder epitopes encoded by multiple trans-sialidase genes were tested for the ability to stimulate a recall CD8(+) T cell response in the peripheral blood from subjects with chronic T. cruzi infection regardless the HLA haplotype. An overall hierarchy of antigenicity was apparent, with the A02 supertype peptides being the most frequently recognized in the Chagas disease population followed by the A03 and the A24 supertype epitopes. CD8(+) T cell responses to promiscuous epitopes revealed that the CD8(+) T cell compartment specific for T. cruzi displays a functional profile with T cells secreting interferon-gamma alone as the predominant pattern and very low prevalence of single IL-2-secreting or dual IFN-gamma/IL-2 secreting T cells denoting a lack of polyfunctional cytokine responses in chronic T. cruzi infection. Conclusions: This study identifies a set of T. cruzi peptides that should prove useful for monitoring immune competence and changes in infection and disease status in individuals with chronic Chagas disease.
引用
收藏
页数:10
相关论文
共 62 条
[41]   Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene [J].
Rodrigues, MM ;
Ribeirao, M ;
Pereira-Chioccola, V ;
Renia, L ;
Costa, F .
INFECTION AND IMMUNITY, 1999, 67 (08) :3855-3863
[42]  
SANTIAGODELPIN EA, 1991, TRANSPLANT P, V23, P1861
[43]   Epitope-based vaccines: an update on epitope identification, vaccine design and delivery [J].
Sette, A ;
Fikes, J .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (04) :461-470
[44]   Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism [J].
Sette, A ;
Sidney, J .
IMMUNOGENETICS, 1999, 50 (3-4) :201-212
[45]   Peptide antagonism and T cell receptor interactions with peptide-MHC complexes [J].
Sykulev, Y ;
Vugmeyster, Y ;
Brunmark, A ;
Ploegh, HL ;
Eisen, HN .
IMMUNITY, 1998, 9 (04) :475-483
[46]   DEPLETION OF T-CELL SUBPOPULATIONS RESULTS IN EXACERBATION OF MYOCARDITIS AND PARASITISM IN EXPERIMENTAL CHAGAS-DISEASE [J].
TARLETON, RL ;
SUN, JR ;
ZHANG, L ;
POSTAN, M .
INFECTION AND IMMUNITY, 1994, 62 (05) :1820-1829
[47]   Chagas disease etiology: Autoimmunity or parasite persistence? [J].
Tarleton, RL ;
Zhang, L .
PARASITOLOGY TODAY, 1999, 15 (03) :94-99
[48]   SUSCEPTIBILITY OF BETA-2-MICROGLOBULIN-DEFICIENT MICE TO TRYPANOSOMA-CRUZI INFECTION [J].
TARLETON, RL ;
KOLLER, BH ;
LATOUR, A ;
POSTAN, M .
NATURE, 1992, 356 (6367) :338-340
[49]   Parasite persistence in the aetiology of Chagas disease [J].
Tarleton, RL .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2001, 31 (5-6) :550-554
[50]  
Threlkeld SC, 1997, J IMMUNOL, V159, P1648